This exploratory study underlines the difficulty in early prediction of GDM development in high-risk women but adds to the evidence that among pregnant women with obesity, insulin secretory dysfunction may be an important discriminator for those who develop GDM. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.